Mineralys Therapeutics, Inc. MLYS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

57/100

3/6 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Mineralys Therapeutics, Inc. (MLYS), dont 21 achats et 28 ventes. Le total des achats d'initiés s'élève à $61.26M et le total des ventes d'initiés à $2.63M.

Les initiés notables ayant une activité récente comprennent Congleton Jon, Karydas Daphne, Ra Capital Management, L.p.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — MLYS

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-31	Congleton Jon	Chief Executive Officer	Vente Informative	453	$27.05	$12.25K	705,051
2026-03-31	Karydas Daphne	Director	Vente Informative	3,000	$25.00	$75K	6,200
2026-03-30	Ra Capital Management, L.p.	Director	Achat Informatif	58,300	$24.16	$1.41M	5,825,521
2026-03-27	Ra Capital Management, L.p.	Director	Achat Informatif	310,700	$23.67	$7.35M	5,767,221
2026-03-17	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	417	$15.44	$6.44K	5,000
2026-03-13	Rodman David Malcom	Chief Medical Officer	Vente Informative	253	$27.82	$7.04K	76,140
2026-03-12	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	6,348	$1.08	$6.86K	25,395
2026-03-09	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	2,171	$16.00	$34.74K	23,876
2026-03-04	Warren Eric	Chief Commercial Officer	Inconnu	357,000	$13.24	$4.73M	-
2026-02-19	Akkaraju Srinivas	10 Percent Owner	Attribution de RSU	6,200	-	-	6,200
2026-02-19	Sblendorio Glenn	Director	Attribution de RSU	6,200	-	-	6,200
2026-02-19	Ra Capital Management, L.p.	Director	Attribution de RSU	6,200	-	-	6,200
2026-02-19	Congleton Jon	Chief Executive Officer	Attribution de RSU	187,900	$28.06	$5.27M	187,900
2026-02-19	Rodman David Malcom	Chief Medical Officer	Attribution de RSU	51,300	$28.06	$1.44M	51,300
2026-02-19	Levy Adam Scott	CFO and Secretary	Attribution de RSU	39,900	-	-	48,538
2026-02-19	Dirocco Derek	Director	Attribution de RSU	6,200	-	-	6,200
2026-02-19	Karydas Daphne	Director	Attribution de RSU	6,200	-	-	6,200
2026-02-19	Slingsby Brian Taylor	10 Percent Owner	Autre (Vente)	6,200	-	-	-
2026-02-19	Gold Alexander M	Director	Attribution de RSU	6,200	-	-	6,200
2026-02-17	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	417	$15.44	$6.44K	5,417
2026-02-13	Rodman David Malcom	Chief Medical Officer	Vente Informative	6,348	$27.58	$175.1K	44,089
2026-02-12	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	6,349	$1.08	$6.86K	31,743
2026-02-09	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	2,171	$16.00	$34.74K	26,047
2026-01-20	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	416	$15.44	$6.42K	5,834
2026-01-14	Rodman David Malcom	Chief Medical Officer	Vente Informative	11,367	$32.61	$370.64K	50,437
2026-01-13	Rodman David Malcom	Chief Medical Officer	Vente Informative	7,709	$32.75	$252.47K	61,804
2026-01-12	Congleton Jon	Chief Executive Officer	Vente Informative	7,117	$33.15	$235.93K	639,151
2026-01-12	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	6,348	$1.08	$6.86K	38,092
2026-01-12	Levy Adam Scott	CFO and Secretary	Vente Informative	10,758	$32.14	$345.72K	8,638
2026-01-09	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	2,170	$16.00	$34.72K	28,218
2026-01-05	Rodman David Malcom	Chief Medical Officer	Exercice d'Options	28,038	$1.08	$30.28K	97,226
2026-01-02	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	20,168	$16.00	$322.69K	84,018
2025-06-13	Rodman David Malcom	Chief Medical Officer	Vente Informative	11,366	$14.60	$165.93K	101,651
2025-06-12	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	6,348	$1.08	$6.86K	95,229
2025-05-14	Rodman David Malcom	Chief Medical Officer	Vente Informative	11,366	$15.29	$173.77K	106,669
2025-05-12	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	6,349	$1.08	$6.86K	101,577
2025-04-14	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	6,348	$1.08	$6.86K	107,926
2025-04-11	Congleton Jon	Chief Executive Officer	Vente Informative	15,319	$12.19	$186.8K	862,289
2025-04-11	Levy Adam Scott	CFO and Secretary	Vente Informative	10,757	$12.06	$129.68K	215,340
2025-04-01	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	1,606	$1.08	$1.73K	114,274
2025-03-13	Akkaraju Srinivas	Director	Achat Informatif	600,000	$13.50	$8.1M	5,674,916
2025-03-13	Ra Capital Management, L.p.	Director	Achat Informatif	1,296,296	$13.50	$17.5M	4,280,051
2025-03-13	Samsara Biocapital Gp, Llc	10 Percent Owner	Achat Informatif	600,000	$13.50	$8.1M	5,674,916
2025-03-13	Slingsby Brian Taylor	10 Percent Owner	Achat Informatif	259,259	$13.50	$3.5M	8,903,838
2025-03-12	Rodman David Malcom	Chief Medical Officer	Exercice d'Options (Vente)	6,349	$1.08	$6.86K	115,880
2025-02-13	Akkaraju Srinivas	10 Percent Owner	Attribution de RSU	32,900	$10.20	$335.58K	32,900
2025-02-13	Sblendorio Glenn	Director	Attribution de RSU	32,900	$10.20	$335.58K	32,900
2025-02-13	Ra Capital Management, L.p.	Director	Attribution de RSU	32,900	$10.20	$335.58K	32,900
2025-02-13	Congleton Jon	Chief Executive Officer	Attribution de RSU	570,000	$10.20	$5.81M	570,000
2025-02-13	Rodman David Malcom	Chief Medical Officer	Attribution de RSU	170,000	$10.20	$1.73M	170,000

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration